RT Book, Section
A1 Caley, Charles F.
A2 Whalen, Karen
A2 Hardin, Heather C.
SR Print(0)
ID 1150202247
T1 Schizophrenia MTM Data Set
T2 Medication Therapy Management: A Comprehensive Approach, 2e
YR 2018
FD 2018
PB McGraw-Hill Education
PP New York, NY
SN 9781260108453
LK accesspharmacy.mhmedical.com/content.aspx?aid=1150202247
RD 2024/04/20
AB KEY  POINTSAppropriate  evaluation  of  schizophrenia  includes  assessment  of  positive  symptoms,  negative  symptoms,  and  cognitive  deficit  severity.  Medication  therapy  management  (MTM)  providers  working  with  patients  with  schizophrenia  should  be  adequately  trained  in  the  use  of  common  rating  scales.MTM  providers  should  educate  patients  to  be  realistic  about  the  expected  outcomes  of  antipsychotic  therapy,  ie,  even  when  medication  is  taken  as  prescribed,  there  will  be  occasional  days  where  symptoms  of  schizophrenia  may  be  bothersome.Nonadherence  is  a  common  medication-related  problem  in  patients  with  schizophrenia.  MTM  providers  should  be  vigilant  for  nonadherence  and  work  with  the  patient  and  provider  to  find  a  regimen  that  promotes  adherence  and  minimizes  adverse  effects  and  drug  cost.Metabolic  syndrome  and  extrapyramidal  symptoms  are  concerning  adverse  effects  of  antipsychotic  drug  therapy.  MTM  providers  should  monitor  for  these  adverse  effects  and  recommend  appropriate  changes  in  therapy  to  help  minimize  their  consequences.